Drug to combat kidney failure from chemotherapy gets FDA approval
A drug to combat kidney failure that some cancer patients suffer after receiving high levels of chemotherapy drug methotrexate has been approved by U.S. regulators with an orphan drug designation. Voraxaze, made by UK-based BTG International, was approved by the U.S. Food and Drug Administration and will be marketed by the company’s U.S. office in […]